U.S. FDA Updates
AI and Machine Learning-Enabled Devices
On May 13, 2024, the U.S. Food and Drug Administration (FDA) published an updated list of authorized AI/ML-enabled medical devices, adding 191 new devices. It brings the total number of authorized devices to 882. The FDA maintains this list to provide transparency about the increasing integration of AI in healthcare. The majority of these devices are in the field of radiology, accounting for 76% of the total, followed by cardiovascular (10%), neurology (4%), hematology (2%), gastroenterology & urology (1.5%), and ophthalmology (1%). The updated list not only highlights the rapid pace of AI adoption in medical devices but also underscores the FDA’s role in ensuring these technologies meet rigorous safety and effectiveness standards.
The FDA’s approach involves a focused review of each device’s overall safety and effectiveness, including an evaluation of appropriate study diversity based on the device’s intended use and technological characteristics. It ensures that AI/ML-enabled devices are not only innovative but also safe and effective for diverse patient populations. Radiology, with the highest number of authorizations, showcases the significant impact AI has on medical imaging, aiding in the detection of malignancies and other critical conditions.
Medical Device Sterilization Town Hall
Discover more from Doctor Trusted
Subscribe to get the latest posts sent to your email.
